-
FDA approval of controversial Alzheimer’s drug could delay discovery of more promising treatments
The U.S. Food and Drug Administration recently approved aducanumab, the first treatment that aims to slow the progression of Alzheimer’s disease. But approval of the drug has provoked mixed reactions from the scientific community. -
We can never let down our guard
The delta variant is on the loose. Only 20% of eligible persons Canadian have been fully vaccinated. Alberta plans to lift all restrictions on July 1. Unexpected surges have occurred in Vietnam, Taiwan, and Singapore. We should never let down our guard if we are to avoid a fourth wave of this pandemic